BPBT
LAB icon

Boston Private Bank & Trust’s Standard BioTools LAB Stock Holding History

Boston Private Bank & Trust’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		$1K Hold
32
– – ﹤0.01% 1014
2014
Q4 		$1K Buy
+32
New +$906 ﹤0.01% 1096

Other funds holding LAB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Boston Private Bank & Trust's LAB Position: Q1 2015 in Review

Boston Private Bank & Trust held its Standard BioTools (LAB) position steady in Q1 2015 at 32 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #1014.

Boston Private Bank & Trust first reported a position in LAB in Q4 2014 and has held it in 2 quarters since. 104 funds tracked by Wall St. Rank hold LAB as of Q1 2015.

  • Boston Private Bank & Trust held 32 shares of Standard BioTools worth $1K as of Q1 2015.
  • Boston Private Bank & Trust left its Standard BioTools share count unchanged in Q1 2015.
  • Standard BioTools made up ﹤0.01% of Boston Private Bank & Trust's portfolio in Q1 2015, its #1014 holding.
  • Boston Private Bank & Trust first reported a position in Standard BioTools in Q4 2014 and has held it in 2 quarters since.
  • 104 funds tracked by Wall St. Rank held Standard BioTools as of Q1 2015.

Based on Boston Private Bank & Trust's 13F filing for Q1 2015, filed 9 Apr 2015.